Huimei Yi

477 total citations
8 papers, 365 citations indexed

About

Huimei Yi is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Huimei Yi has authored 8 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Huimei Yi's work include Cancer, Lipids, and Metabolism (3 papers), Cancer-related Molecular Pathways (2 papers) and Adenosine and Purinergic Signaling (1 paper). Huimei Yi is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Cancer-related Molecular Pathways (2 papers) and Adenosine and Purinergic Signaling (1 paper). Huimei Yi collaborates with scholars based in China, United States and France. Huimei Yi's co-authors include Xiyun Deng, Guangchun He, Xiaojun Tao, Shichao Yan, Hui Yao, Chao Chen, Lu Lu, Di Wu, Lu Lu and Shujun Fu and has published in prestigious journals such as ACS Applied Materials & Interfaces, Frontiers in Oncology and Nanoscale Research Letters.

In The Last Decade

Huimei Yi

8 papers receiving 361 citations

Peers

Huimei Yi
Arul Goel United States
Zide Chen China
Pihong Li China
Anxin Gu China
Huimei Yi
Citations per year, relative to Huimei Yi Huimei Yi (= 1×) peers Zhongjian Yu

Countries citing papers authored by Huimei Yi

Since Specialization
Citations

This map shows the geographic impact of Huimei Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huimei Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huimei Yi more than expected).

Fields of papers citing papers by Huimei Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huimei Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huimei Yi. The network helps show where Huimei Yi may publish in the future.

Co-authorship network of co-authors of Huimei Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Huimei Yi. A scholar is included among the top collaborators of Huimei Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huimei Yi. Huimei Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zhang, Qiuting, Huimei Yi, Hui Yao, et al.. (2021). Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis. Journal of Cancer. 12(13). 4075–4085. 99 indexed citations
2.
Yi, Huimei, Ying Li, Yuan Tan, et al.. (2021). Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives. Frontiers in Oncology. 11. 648139–648139. 24 indexed citations
3.
Yan, Shichao, Zhangyong Hong, Jing Wang, et al.. (2020). CD133 peptide-conjugated pyropheophorbide-a as a novel photosensitizer for targeted photodynamic therapy in colorectal cancer stem cells. Biomaterials Science. 9(6). 2020–2031. 17 indexed citations
4.
Yi, Huimei, Qiuting Zhang, Lu Lu, et al.. (2020). Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells. Journal of Cancer. 11(13). 3713–3716. 10 indexed citations
5.
Wu, Di, Chen Yao, Shun Wen, et al.. (2019). Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells. Nanoscale Research Letters. 14(1). 314–314. 23 indexed citations
6.
Lu, Lu, Huimei Yi, Chao Chen, et al.. (2018). Nucleolar stress: is there a reverse version?. Journal of Cancer. 9(20). 3723–3727. 11 indexed citations
7.
Song, Liujiang, Xiaojun Tao, Lin Li, et al.. (2018). Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy. ACS Applied Materials & Interfaces. 10(8). 7022–7030. 22 indexed citations
8.
Chen, Chao, Lu Lu, Shichao Yan, et al.. (2017). Autophagy and doxorubicin resistance in cancer. Anti-Cancer Drugs. 29(1). 1–9. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026